You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


UK approval for MSD/Ridgeback’s COVID-19 antiviral med

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorised MSD and Ridgeback Therapeutics’ COVID-19 antiviral medicine molnupiravir.